Magnesium Ions Promote In Vitro Rat Bone Marrow Stromal Cell Angiogenesis Through Notch Signaling

Overview

Journal Biol Trace Elem Res

Date 2022 Jul 23

PMID 35870071

Authors

Haotian Qin

Jian Weng

Bo Zhou

Weifei Zhang

Guoqing Li

Yingqi Chen

Tiantian Qi

Yuanchao Zhu

Fei Yu

Hui Zeng

Affiliations

Soon will be listed here.

Abstract

Bone defects are often caused by trauma or surgery and can lead to delayed healing or even bone nonunion, thereby resulting in impaired function of the damaged site. Magnesium ions and related metallic materials play a crucial role in repairing bone defects, but the mechanism remains unclear. In this study, we induced the angiogenic differentiation of bone marrow stromal cells (BMSCs) with different concentrations of magnesium ions. The mechanism was investigated using γ-secretase inhibitor (DAPT) at different time points (7 and 14 days). Angiogenesis, differentiation, migration, and chemotaxis were detected using the tube formation assay, wound-healing assay, and Transwell assay. Besides, we analyzed mRNA expression and the angiogenesis-related protein levels of genes by RT-qPCR and western blot. We discovered that compared with other concentrations, the 5 mM magnesium ion concentration was more conducive to forming tubes. Additionally, hypoxia-inducible factor 1 alpha (Hif-1α) and endothelial nitric oxide (eNOS) expression both increased (p < 0.05). After 7 and 14 days of induction, 5 mM magnesium ion group tube formation, migration, and chemotaxis were enhanced, and the expression of Notch pathway genes increased. Moreover, expression of the Notch target genes hairy and enhancer of split 1 (Hes1) and Hes5 (hairy and enhancer of split 5), as well as the angiogenesis-related genes Hif-1α and eNOS, were enhanced (p < 0.05). However, these trends did not occur when DAPT was applied. This indicates that 5 mM magnesium ion is the optimal concentration for promoting the angiogenesis and differentiation of BMSCs in vitro. By activating the Notch signaling pathway, magnesium ions up-regulate the downstream genes Hes1 and Hes5 and the angiogenesis-related genes Hif-1α and eNOS, thereby promoting the angiogenesis differentiation of BMSCs. Additionally, magnesium ion-induced differentiation enhances the migration and chemotaxis of BMSCs. Thus, we can conclude that magnesium ions and related metallic materials promote angiogenesis to repair bone defects. This provides the rationale for developing artificial magnesium-containing bone materials through tissue engineering.

Citing Articles

Sol-gel synthesis of magnesium oxide nanoparticles and their evaluation as a therapeutic agent for the treatment of osteoarthritis.

Mei S, Jiang F, Liu N, Feng Z, Zheng Y, Yang W Nanomedicine (Lond). 2024; 19(23):1867-1878.

PMID: 39109508 PMC: 11457622. DOI: 10.1080/17435889.2024.2382421.

Preparation of a novel antibacterial magnesium carbonate coating on a titanium surface and its biocompatibility.

Xiang S, Zhang C, Guan Z, Li X, Liu Y, Feng G RSC Adv. 2024; 14(15):10516-10525.

PMID: 38567331 PMC: 10985587. DOI: 10.1039/d4ra00399c.

Exogeneous metal ions as therapeutic agents in cardiovascular disease and their delivery strategies.

Hong X, Tian G, Zhu Y, Ren T Regen Biomater. 2024; 11:rbad103.

PMID: 38173776 PMC: 10761210. DOI: 10.1093/rb/rbad103.

Magnesium-containing bioceramics stimulate exosomal miR-196a-5p secretion to promote senescent osteogenesis through targeting /MAPK signaling axis.

Qi L, Fang X, Yan J, Pan C, Ge W, Wang J Bioact Mater. 2023; 33:14-29.

PMID: 38024235 PMC: 10661166. DOI: 10.1016/j.bioactmat.2023.10.024.

References

van de Vijfeijken S, Munker T, Spijker R, Karssemakers L, Vandertop W, Becking A . Autologous Bone Is Inferior to Alloplastic Cranioplasties: Safety of Autograft and Allograft Materials for Cranioplasties, a Systematic Review. World Neurosurg. 2018; 117:443-452.e8. DOI: 10.1016/j.wneu.2018.05.193. View

Chen X, Gao C, Chu X, Zheng C, Luan Y, He X . VEGF-Loaded Heparinised Gelatine-Hydroxyapatite-Tricalcium Phosphate Scaffold Accelerates Bone Regeneration Enhancing Osteogenesis-Angiogenesis Coupling. Front Bioeng Biotechnol. 2022; 10:915181. PMC: 9216719. DOI: 10.3389/fbioe.2022.915181. View

Tao Z, Zhou W, Tu K, Huang Z, Zhou Q, Sun T . Treatment study of distal femur for parathyroid hormone (1-34) and β-tricalcium phosphate on bone formation in critical-sized defects in osteopenic rats. J Craniomaxillofac Surg. 2015; 43(10):2136-43. DOI: 10.1016/j.jcms.2015.09.004. View

Sukegawa S, Kanno T, Matsumoto K, Sukegawa-Takahashi Y, Masui M, Furuki Y . Complications of a poly-L-lactic acid and polyglycolic acid osteosynthesis device for internal fixation in maxillofacial surgery. Odontology. 2018; 106(4):360-368. DOI: 10.1007/s10266-018-0345-6. View

Romani A . Beneficial Role of Mg in Prevention and Treatment of Hypertension. Int J Hypertens. 2018; 2018:9013721. PMC: 6016150. DOI: 10.1155/2018/9013721. View

Wang J, Xu J, Hopkins C, Chow D, Qin L . Biodegradable Magnesium-Based Implants in Orthopedics-A General Review and Perspectives. Adv Sci (Weinh). 2020; 7(8):1902443. PMC: 7175270. DOI: 10.1002/advs.201902443. View

Bobe K, Willbold E, Haupt M, Reebmann M, Morgenthal I, Andersen O . Biodegradable open-porous scaffolds made of sintered magnesium W4 and WZ21 short fibres show biocompatibility in vitro and in long-term in vivo evaluation. Acta Biomater. 2022; 148:389-404. DOI: 10.1016/j.actbio.2022.06.005. View

Maes C . Role and regulation of vascularization processes in endochondral bones. Calcif Tissue Int. 2013; 92(4):307-23. DOI: 10.1007/s00223-012-9689-z. View

Peng Y, Wu S, Li Y, Crane J . Type H blood vessels in bone modeling and remodeling. Theranostics. 2020; 10(1):426-436. PMC: 6929606. DOI: 10.7150/thno.34126. View

10.

Kusumbe A, Ramasamy S, Adams R . Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 2014; 507(7492):323-328. PMC: 4943525. DOI: 10.1038/nature13145. View

11.

Wang L, Zhou F, Zhang P, Wang H, Qu Z, Jia P . Human type H vessels are a sensitive biomarker of bone mass. Cell Death Dis. 2017; 8(5):e2760. PMC: 5520742. DOI: 10.1038/cddis.2017.36. View

12.

Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K . Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther. 2022; 7(1):95. PMC: 8948217. DOI: 10.1038/s41392-022-00934-y. View

13.

Hall D, Kovall R . Structurally conserved binding motifs of transcriptional regulators to notch nuclear effector CSL. Exp Biol Med (Maywood). 2019; 244(17):1520-1529. PMC: 6920672. DOI: 10.1177/1535370219877818. View

14.

Diaz-Tocados J, Herencia C, Martinez-Moreno J, Montes de Oca A, Rodriguez-Ortiz M, Vergara N . Magnesium Chloride promotes Osteogenesis through Notch signaling activation and expansion of Mesenchymal Stem Cells. Sci Rep. 2017; 7(1):7839. PMC: 5552799. DOI: 10.1038/s41598-017-08379-y. View

15.

Onder S, Calikoglu-Koyuncu A, Kazmanli K, Urgen M, Kok F, Torun-Kose G . Magnesium doping on TiN coatings affects mesenchymal stem cell differentiation and proliferation positively in a dose-dependent manner. Biomed Mater Eng. 2018; 29(4):427-438. DOI: 10.3233/BME-181000. View

16.

Caolo V, Molin D, Post M . Notch regulation of hematopoiesis, endothelial precursor cells, and blood vessel formation: orchestrating the vasculature. Stem Cells Int. 2012; 2012:805602. PMC: 3328335. DOI: 10.1155/2012/805602. View

17.

Lee S, Chen T, Barber C, Jordan M, Murdock J, Desai S . Autocrine VEGF signaling is required for vascular homeostasis. Cell. 2007; 130(4):691-703. PMC: 3010851. DOI: 10.1016/j.cell.2007.06.054. View

18.

Maes C, Clemens T . Angiogenic-osteogenic coupling: the endothelial perspective. Bonekey Rep. 2014; 3:578. PMC: 4197481. DOI: 10.1038/bonekey.2014.73. View

19.

Li X, Wang Y, Shi L, Li B, Li J, Wei Z . Magnetic targeting enhances the cutaneous wound healing effects of human mesenchymal stem cell-derived iron oxide exosomes. J Nanobiotechnology. 2020; 18(1):113. PMC: 7429707. DOI: 10.1186/s12951-020-00670-x. View

20.

Montazersaheb S, Kabiri F, Saliani N, Nourazarian A, Biray Avci C, Rahbarghazi R . Prolonged incubation with Metformin decreased angiogenic potential in human bone marrow mesenchymal stem cells. Biomed Pharmacother. 2018; 108:1328-1337. DOI: 10.1016/j.biopha.2018.09.135. View